Scarica l'app Stockscreener
26.62
5.94%
-1.68
Dopo l'orario di chiusura:
26.62
Precedente Chiudi:
$28.30
Aprire:
$28.773
Volume 24 ore:
36,464
Relative Volume:
0.13
Capitalizzazione di mercato:
$35.70M
Reddito:
-
Utile/perdita netta:
$-24.14M
Rapporto P/E:
-1.9035
EPS:
-13.985
Flusso di cassa netto:
$-22.40M
1 W Prestazione:
-18.39%
1M Prestazione:
+5.93%
6M Prestazione:
+181.54%
1 anno Prestazione:
+230.27%
Intervallo 1D:
$26.62
$28.77
Intervallo di 1 settimana:
$26.31
$32.40
Portata 52W:
$5.25
$36.76
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Nome
Sensei Biotherapeutics Inc
Settore
Industria
Telefono
(240) 243-8000
Indirizzo
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Compare SNSE vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
26.62 | 39.04M | 0 | -24.14M | -22.40M | -13.98 |
VRTX
Vertex Pharmaceuticals Inc
|
427.38 | 109.41B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
707.06 | 76.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
781.72 | 48.20B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
309.49 | 40.31B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
295.27 | 33.13B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-20 | Iniziato | Leerink Partners | Outperform |
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2024-05-14 | Iniziato | Stephens | Overweight |
| 2021-07-01 | Downgrade | Berenberg | Buy → Hold |
| 2021-06-29 | Downgrade | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Iniziato | Berenberg | Buy |
| 2021-03-01 | Iniziato | Citigroup | Buy |
| 2021-03-01 | Iniziato | Oppenheimer | Outperform |
| 2021-03-01 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Sensei Biotherapeutics Inc Borsa (SNSE) Ultime notizie
[144] Sensei Biotherapeutics, Inc. SEC Filing - Stock Titan
Sensei Biotherapeutics (SNSE) price target increased by 53.85% to 51.00 - MSN
Sensei Biotherapeutics (NASDAQ: SNSE) registers 24.87M resale shares - Stock Titan
Faeth-focused recapitalization at Sensei (NASDAQ: SNSE) reshapes ownership and adds $200M - Stock Titan
Is Sensei Biotherapeutics (SNSE) stock a favorable investment idea | Q4 2025: EPS Exceeds ExpectationsCrowd Breakout Signals - Xã Thanh Hà
Is Sensei Biotherapeutics (SNSE) stock facing investor skepticism | Q4 2025: Earnings Beat EstimatesHot Momentum Watchlist - Cổng thông tin điện tử tỉnh Lào Cai
Is Sensei Biotherapeutics (SNSE) stock relatively low risk (Market Focus) 2026-04-22High Beta Stocks - Xã Vĩnh Công
Sensei Biotherapeutics Inc Live Share Prices and Trades. SNSE.US Live Streaming Share Prices. - London South East
Leerink initiates Sensei Biotherapeutics stock at Outperform, $50 target By Investing.com - Investing.com South Africa
Leerink initiates Sensei Biotherapeutics stock at Outperform, $50 target - Investing.com
Sensei Biotherapeutics: If Proposals Are Approved, COO Anand Parikh Is Expected to Become CEO - Moomoo
Sensei Biotherapeutics Announces Leadership and Board Transitions - TipRanks
Christopher W. Gerry, Thomas Ricks, and Kristian Humer Tender Conditional Resignations From Sensei Biotherapeutics Board, Effective in June - Moomoo
Leadership and board overhaul outlined by Sensei Biotherapeutics (NASDAQ: SNSE) - Stock Titan
Faeth deal shifts control; Sensei Biotherapeutics (NASDAQ: SNSE) seeks shareholder approvals - Stock Titan
Form 8-K/ACurrent report: [Amend] - ADVFN
Sensei Biotherapeutics (SNSE) details Faeth acquisition, PIPE and going-concern warning - Stock Titan
Sensei Biotherapeutics (SNSE) grants PFO 80,000 stock options - Stock Titan
Director at Sensei Biotherapeutics (SNSE) receives 23,100 stock options - Stock Titan
Sensei Biotherapeutics Inc and Faeth Therapeutics Acquisition Call Transcript - GuruFocus
Macro Review: Is Sensei Biotherapeutics Inc in a bullish channel2026 Trading Recap & Community Consensus Trade Signals - baoquankhu1.vn
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - BioSpace
Aug Update: What is the Moat Score of Sensei Biotherapeutics IncQuarterly Market Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Should I Buy Sensei Biotherapeutics (SNSE) Stock Today | Price at $33.00, Up 6.38%Elite Alerts - Xã Thanh Hà
Investor Mood: What is the Moat Score of Sensei Biotherapeutics IncQuarterly Profit Summary & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth Therapeutics - Legal Desire Media and Insights
AI Stocks: Can Sensei Biotherapeutics Inc grow without dilution2026 Catalysts & Trade Opportunity Analysis Reports - baoquankhu1.vn
Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - biospace.com
Sensei Biotherapeutics (SNSE) Sets Ambitious Clinical Goals for 2026 - GuruFocus
Faeth acquisition and $200M raise reshape Sensei Biotherapeutics (NASDAQ: SNSE) - stocktitan.net
Sensei Biotherapeutics Acquires Faeth, Advances PIKTOR Cancer Program with $200M Financing and Reports 2025 Financial Results - Minichart
Sensei Biotherapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update - TradingView
Sensei Biotherapeutics (NASDAQ: SNSE) 2025 loss narrows, lands $200M - Stock Titan
Aug Chart Watch: What is Sensei Biotherapeutics Incs TAM Total Addressable Market2026 WrapUp & Real-Time Market Trend Scan - baoquankhu1.vn
If You Invested $1,000 in Sensei Biotherapeutics, Inc. (SNSE) - Stock Titan
Decliners Report: Does Sensei Biotherapeutics Inc have pricing power2026 Sector Review & Long-Term Safe Investment Plans - baoquankhu1.vn
Aug Technicals: What is the Moat Score of Sensei Biotherapeutics Inc2026 PreEarnings & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Momentum Shift: Can Sensei Biotherapeutics Inc be the next market leaderWeekly Profit Recap & Capital Efficient Trade Techniques - baoquankhu1.vn
SNSE.O PE Ratio & Valuation, Is SNSE.O Overvalued - Intellectia AI
The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology - GlobeNewswire Inc.
Anand Kiran Parikh Net Worth (2026) - GuruFocus
Sensei Biotherapeutics announces inducement grants under Nasdaq listing rule - TipRanks
Sensei Biotherapeutics (SNSE) Announces Stock Option Grant to Ne - GuruFocus
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Sensei Biotherapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Why Sensei Biotherapeutics Inc. stock is favored by pension funds2026 Pullbacks & Reliable Entry Point Trade Alerts - Naître et grandir
Update Recap: How buybacks impact Sensei Biotherapeutics Inc. stock valueCEO Change & Comprehensive Market Scan Insights - Naître et grandir
Published on: 2026-03-07 01:25:22 - Naître et grandir
Sensei Biotherapeutics Inc Azioni (SNSE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):